Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance
NCT01532518
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Colic
Interventions
DRUG:
Nepadutant
Sponsor
Menarini Group